Abstract
Introduction:
Using a digital process that leverages electronic health records (EHRs) can ease many of the challenges presented by the traditional enrollment process for clinical trials. We tested if automated batch enrollment using a technology-enabled subject recruitment system (TESRS) enhances recruitment while preserving representation of research subjects for the study population in our study setting.
Methods:
An ongoing community-based prospective adult cohort study was used to randomize 600 subjects who were eligible by age and residential address to TESRS (n = 300) and standard mailing method (n = 300), respectively, for 3 months. Then, TESRS was initiated and included automatic identification of patients’ preference for being contacted (online patient portal vs postal mail) from EHRs and automatic sending out of invitation letters followed by completion of a short online survey for checking eligibility and the digital consent process if eligible. We compared (1) median time to consent from invitation sent out per subject and total subjects recruited after a 3-month recruitment period, (2) the estimated study staff’s time, and (3) representation of sociodemographic characteristics (e.g., age, sex, race, SES measured by HOUSES index, and rural residence) between subjects recruited via TESRS and those via traditional mailing methods.
Results:
Median age of randomized subjects (n = 600) was 63 years with 52.0% female and 89.2% non-Hispanic White. Over a 3-month period, results showed consent rate via TESRS was 13% (39/297) similar to 11% (31/295) via standard mailing. However, recruitment was significantly faster with the TESRS approach (median 7 vs 26 days) given the study staff’s effort. Study staff’s time saved by using TESRS compared to standard mailing approach was estimated at 40 min per subject (equivalent to 200 h for 300 subjects). No significant differences in characteristics of research subjects from the study population were found.
Conclusion:
Our study demonstrated the utility of TESRS as a subject recruitment digital technology which significantly enhanced the recruitment effort while reducing the study staff burden of recruitment while maintaining the consistency of characteristics of recruited subjects. The strategy and support for implementing and testing TESRS in other study settings should be considered.
Introduction
In the era of electronic health records (EHRs), enrollment of a large number of research subjects in clinical trials or prospective studies can be challenging but can be facilitated by leveraging EHRs. For example, a qualitative study showed most researchers, institutional review board chairs, and primary care physicians considered it acceptable for researchers to contact patients directly. 1 Patient’s preferred communication methods are often documented in EHRs (e.g., online patient portal vs postal mail) along with most of the information that helps determine eligibility for different studies (e.g., demographics, comorbidities). A batch enrollment for a recent digital clinical trial utilized EHRs for the identification of eligible subjects, sorting out their preferred communication methods, and sending out automatic invitation letters to target recruitment.2,3
Despite the widespread utilization of EHR screening for recruitment purposes, there are ongoing challenges in terms of technical aspects, governance, and regulatory requirements. 4 The ethical and legal imperatives of the digital consent process have also been raised due to the potential of not fully understanding the information, especially potential risks, harms, or side effects of a treatment. 5 However, studies with no greater than minimal risk (e.g., observational studies) may reap great benefits for timely subject recruitment by utilizing automated batch enrollment, especially for time-sensitive studies such as COVID-19-related observational studies.2,3 A recent review on digital tools in the informed consent process showed digital technologies for informed consent were not found to negatively affect any of the outcomes studied, and overall, multimedia tools seem desirable. 6 However, none of the studies compared and reported the utility of using digital technology tools in informed consent for subject recruitment as primary outcomes by comparing with the traditional approach (e.g., standard mailing). Batch enrollment using digital tools may also introduce selection bias due to difficulty in accessing technology by some patients (e.g., digital screening and consenting).7,8 This bias may further exclude vulnerable populations (e.g., older people, people from lower socioeconomic status, or rural residents). Herein, we aimed to test the utility of automated batch enrollment (named technology-enabled subject recruitment system [TESRS]) by comparing study staff’s time saved for subject recruitment and representation of sociodemographic characteristics of study subjects who were recruited via TESRS versus the traditional standard mailing approach.
Materials and Methods
Study Setting and Population
According to 2010 U.S. census data, age, sex, and ethnic characteristics of Olmsted County, Minnesota, residents (where 89% of the study subjects lived) were similar to those of the state of Minnesota and the Upper Midwest (19) except for a large proportion of residents working in the health care industry. We enrolled patients paneled in the Mayo Clinic primary care practice, Rochester, Minnesota, who resided in Olmsted and 6 surrounding counties using electronic health records (EHRs), and the details of the study design were previously reported. 9
Study Design and Cohort
We tested if the TESRS approach helped recruit new subjects of an expanded, ongoing community-based prospective cohort study assessing burden of respiratory infections. 9 As a proof-of-concept study, for comparison purposes, we randomized 600 subjects who were eligible by age and residential address to TESRS (n = 300) and standard mailing method (n = 300), respectively, during the subject recruitment period (July 27, 2021-October 25, 2021). Randomization was done by SAS (statistical software) and stratified based on a history of confirmed COVID-19 to account for willingness to participate in a research study during the COVID-19 pandemic, not necessarily due to biologic impact of COVID-19.

Involved digital systems for TESRS and work and information flow diagram.
Results
Summary of characteristics of study subjects
Median age of randomized subjects (n = 600) was 63 years with 52.0% female and 89.2% non-Hispanic White. Supplemental Table 1 summarizes characteristics of study subjects who were invited by TESRS versus a traditional standard mailing approach after randomization. Overall, there was no significant difference in age, race/ethnicity, socioeconomic status defined by HOUSES index, rural status, and history of COVID-19 positivity, except sex (male 52.7% in TESRS vs 44.1% in standard mailing arm; P = 0.036). Three subjects for TESRS and 5 for the standard mailing arm were excluded, respectively, in the subsequent analysis as they were found to have died or moved out of the study setting before or after the letters were sent out.
Study Staff Time Spent for Recruitment
Table 1 shows estimated time for study staff’s effort for subject recruitment process (e.g., organizing and sending out the list of eligible subjects as a batch). Study staff’s time saved by using TESRS compared to standard mailing approach was estimated at 40 min per subject (equivalent to 200 h for 300 subjects). The median time for invited subjects to consent via TESRS was significantly shorter than the traditional approach (median 7 days [interquartile range: 0-14] vs 26 days [interquartile range: 20-36] with standard mailing (P < .001) (see Supplemental Table 2 for details).
Comparisons of Recruitment Effort and Process by Study Staff and Estimated Time Between the Approach Using TESRS and the Standard Mailing Approach.
Some institutions may not have this service, so individual investigative team may need to put together all materials to be sent out to eligible subjects, which will add another layer of coordinators’ time.
For the individuals that signed consent electronically (TESRS), the data were electronically imported to REDCap by our statistics team. This was set up as an automatic process and ran every night. The manual data entry would be needed for those that did not prefer electronic consent.
Representation of a Sample of Recruited Subjects for the Study Population
Subjects who had the preference to be contacted via Mayo Clinic’s online patient portal (TESRS) were more likely to respond to research invitation (i.e., pre-screening rate 28.6%) compared to those who did not (13.6%; P < .001) (Supplemental Table 2), in addition to significantly faster response time with the TESRS approach (median 7 vs 26 days) as described above. The final number of subjects accrued (i.e., the subject completed the initial study visit) after 3 months were similar (32 vs 31) (see Table 2), and characteristics of subjects accrued via TESRS did not differ significantly from those via standard mailing in age, sex, race/ethnicity, SES, and history of COVID-19. There was no significant difference in proportion of rural residents enrolled to our study between the 2 approaches.
Comparison of Sociodemographics of Subjects Accrued* Between TESRS and Standard Mailing.
Cochran-Armitage trend test.
Chi-square P value.
HOUSES: Individual-level socioeconomic status (SES) measure (the higher HOUSES, the higher SES).
Subjects that had been accrued after 3 months.
Discussion
To our knowledge, this is the first study that assessed the utility of TESRS for online versus traditional mailing invitation followed by a digital screening and consenting process. Timely subject recruitment is challenging for large clinical trials or observational studies, but it is often crucial for studies addressing time-sensitive outcomes such as COVID-19-related studies. Our study results showed that TESRS enabled us to more efficiently recruit a large number of subjects while keeping representativeness of recruited subjects for the study population compared to the traditional recruitment approach (e.g., standard mailing). While this system may be ideal for digital or fully decentralized clinical trials or observational studies,2,3 traditional studies requiring onsite visits such as ours also found benefits of TESRS for timely and efficient subject recruitment. Indeed, after reviewing preliminary data 1 month after starting this pilot trial, our team switched our primary subject recruitment process to that using TESRS for recruiting the rest of the subjects (~800) to reach our target sample size.
Study staff’s recruitment effort requires a variety of study-specific, subject-dependent, and labor-intensive tasks. Sometimes, it requires significant additional time for addressing unanticipated challenges for subject recruitment. Table 1 summarized a study staff’s activities during the subject recruitment process, comparing between TESRS and standard mailing approach. If TESRS is applied to a large study, for example, recruiting 4,000 subjects, about 1.0 Full Time Equivalent (FTE) of a study coordinator’s time could be saved with TESRS. TESRS enabled our study team to complete subject recruitment of ~800 within 3 months without hiring additional study coordinators.
Our study has some limitations. First, immediate application of TESRS to other study settings may be uncertain or limited as institutions may not have all digital systems and the interface needed for operating TESRS (see the section of Technology enabled subject recruitment system (TESRS) in the Materials and Methods). Although it may take longer and be costly to set up this system initially, even part of the process (e.g., digital screening) may help reduce effort and time of traditional recruitment processes (e.g., phone screening). Second, digital consenting process may not address individual’s questions before they determine participation, especially for people from different cultural backgrounds. REDCap eConsent framework which is a validated tool to provide a personalized consent experience through a consent document that utilizes several methods including avatars, contextual glossary information supplements, and videos will enhance TESRS if adopted to TESRS, especially for multi-site studies. 14 Third, our study population is predominantly non-Hispanic White raising uncertainty of whether our study findings can be generalizable in other study settings such as those with more ethnic minorities or people with limited English proficiency. However, despite the reported potential disparities in access to digital technology,8,15,16 our study showed that characteristics of the accrued subjects through TESRS did not differ significantly from those via standard mailing in age, sex, race/ethnicity, SES, rural status, and history of COVID-19. Given this feature of TESRS, it is promising to continue to develop and refine this digital recruitment technology for various studies, and it may be worthy of testing this system in other study settings. Lastly, this exploratory study is based on a relatively small sample size.
Conclusion
Our study demonstrated the utility of TESRS as a subject recruitment digital technology which significantly enhanced the recruitment effort while reducing the study staff burden of recruitment and maintaining the consistency of characteristics of recruited subjects. The strategy and support for implementing and testing the TESRS in other study settings should be considered.
Supplemental Material
sj-docx-1-jpc-10.1177_21501319231194967 – Supplemental material for Application of Innovative Subject Recruitment System for Batch Enrollment: A Pilot Study
Supplemental material, sj-docx-1-jpc-10.1177_21501319231194967 for Application of Innovative Subject Recruitment System for Batch Enrollment: A Pilot Study by Chung-Il Wi, Katherine S. King, Euijung Ryu, Traci L. Natoli, Ryan P. Miller, Matthew J. Spiten, Bijan J. Borah, Paul Y. Takahashi, Xiaoxi Yao, Peter A. Noseworthy, Robert J. Pignolo and Young J. Juhn in Journal of Primary Care & Community Health
Footnotes
Acknowledgements
We greatly thank the staff of the Precision Population Science Lab, Reporting Systems & Solutions, Ambulatory Documentation Systems, Research CTMS, Survey Research Center, Data Delivery Applications, Innovate & Diffuse, and Enterprise Solution Activation & Services of Mayo Clinic. We thank Ms. Kelly Okeson for her administrative assistance for the manuscript preparation.
Credit Author Statement
All authors meet the criteria for authorship based on the following 4 requirements: (1) substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; (2) drafting the work or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Specifically, YJ had full access to all the data in the study, takes responsibility for the integrity of the data and the accuracy of the data analysis, and had authority over manuscript preparation and the decision to submit the manuscript for publication. Study concept and design: CW, KK, ER, NT, RP, and YJ. Acquisition, analysis, or interpretation of data: CW, KK, ER, NT, RM, MS, BB, PT, XY, PN, RP, and YJ. Drafting of the manuscript: CW. Critical revision of the manuscript for important intellectual content: all authors.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This collaborative observational study was supported by a research grant from GlaxoSmithKline Biologicals SA.
Supplemental Material
Supplemental material for this article is available online.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
